CHA Vaccine Research Institute Company Description

Cha Vaccine Research Institute Co., Ltd., a research-oriented biotechnology company, researches and develops a range of vaccine products targeting infectious and chronic diseases.

Its product pipeline includes HBV vaccine that is in Phase IIb planning for the prevention of hepatitis B; Adjuvanted HBV vaccine that is in Phase I/IIa for the treatment of chronic hepatitis B; and VZV Vaccine, which is in pre-clinical planning stage for the prevention of Herpes Zoster.

The company also develops influenza vaccine, recombinant MBL, TB vaccine, and cancer vaccine. Cha Vaccine Research Institute Co., Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea.

CHA Vaccine Research Institute

Country	South Korea
Founded	2000
Industry	Biological Products, Except Diagnostic Substances
CEO	Jungsun Yum

Contact Details

Address: 560 Dunchon-daero Seongnam, 13230 South Korea
Phone	82 31 737 8208
Website	chavaccine.com

Stock Details

Ticker Symbol	261780
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2836

Key Executives

Name	Position
Jungsun Yum	Chief Executive Officer